1. Home
  2. ATON vs ACXP Comparison

ATON vs ACXP Comparison

Compare ATON & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AlphaTON Capital Corp.

ATON

AlphaTON Capital Corp.

HOLD

Current Price

$0.33

Market Cap

9.3M

Sector

Energy

ML Signal

HOLD

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

HOLD

Current Price

$1.94

Market Cap

8.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATON
ACXP
Founded
1973
2017
Country
British Virgin Islands
United States
Employees
4
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3M
8.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ATON
ACXP
Price
$0.33
$1.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$2.00
$95.50
AVG Volume (30 Days)
6.1M
103.4K
Earning Date
07-24-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.29
52 Week High
$13.80
$8.34

Technical Indicators

Market Signals
Indicator
ATON
ACXP
Relative Strength Index (RSI) 44.61 42.73
Support Level $0.28 $1.82
Resistance Level $0.35 $2.30
Average True Range (ATR) 0.03 0.15
MACD 0.01 0.05
Stochastic Oscillator 71.54 46.81

Price Performance

Historical Comparison
ATON
ACXP

About ATON AlphaTON Capital Corp.

AlphaTON Capital Corp is a specialized digital asset treasury company focused on building and managing a strategic reserve of TON tokens and developing the Telegram ecosystem. The company implements a comprehensive treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, it provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

Share on Social Networks: